CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
CHR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 9 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make CHR suitable for value investing!
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
CHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -17.42%, CHR perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
With a Return On Equity value of -47.80%, CHR perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.29%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 5.50%.
The last Return On Invested Capital (6.29%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
With a decent Operating Margin value of 6.77%, CHR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
The Gross Margin of CHR (65.04%) is better than 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
CHR has less shares outstanding than it did 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
2.2 Solvency
CHR has an Altman-Z score of 0.85. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.85, CHR is doing worse than 66.67% of the companies in the same industry.
CHR has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR would need 3.86 years to pay back of all of its debts.
CHR has a Debt to FCF ratio of 3.86. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
CHR has a Debt/Equity ratio of 0.68. This is a neutral value indicating CHR is somewhat dependend on debt financing.
The Debt to Equity ratio of CHR (0.68) is better than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 0.85 |
ROIC/WACC0.75
WACC8.39%
2.3 Liquidity
A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
CHR has a Current ratio of 1.22. This is in the better half of the industry: CHR outperforms 66.67% of its industry peers.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.71, CHR perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
CHR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
CHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.15%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.82% on average per year.
Based on estimates for the next years, CHR will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.46 indicates a correct valuation of CHR.
CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 88.89% of the companies in the same industry.
CHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.15.
The Price/Forward Earnings ratio is 10.95, which indicates a very decent valuation of CHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, CHR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 10.95 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 88.89% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHR is valued cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.45 | ||
| EV/EBITDA | 4.99 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
CHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR (6/30/2025, 7:00:00 PM)
22.35
+0.71 (+3.28%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap591.38M
Analysts78.18
Price Target28.23 (26.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)3.2%
PT rev (3m)1.57%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)6.33%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 10.95 | ||
| P/S | 0.42 | ||
| P/FCF | 5.45 | ||
| P/OCF | 3.96 | ||
| P/B | 1.15 | ||
| P/tB | 1.17 | ||
| EV/EBITDA | 4.99 |
EPS(TTM)1.66
EY7.43%
EPS(NY)2.04
Fwd EY9.14%
FCF(TTM)4.1
FCFY18.35%
OCF(TTM)5.65
OCFY25.27%
SpS52.7
BVpS19.51
TBVpS19.18
PEG (NY)0.22
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.85 |
F-Score6
WACC8.39%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%